Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research

被引：21

作者：

Bissonnette, R. ^{[1
,2
]}

Saint-Cyr Proulx, E. ^{[1
]}

Jack, C. ^{[1
]}

Maari, C. ^{[1
]}

机构：

[1] Innovaderm Res Inc, Montreal, PQ, Canada

[2] Innovaderm Res, 3530 St Laurent Blvd,Suite 300, Montreal, PQ H2X 2V1, Canada

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 06期

关键词：

TOPICAL WBI-1001; DOUBLE-BLIND; EFFICACY; SAFETY; CREAM;

D O I：

10.1111/jdv.18925

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Tapinarof is a topical, aryl-hydrocarbon receptor agonist that has recently received FDA-approval for the treatment of psoriasis. This novel therapeutic has also been shown to be effective for atopic dermatitis and is currently in phase 3 for this indication. Beyond good efficacy and fast onset of action in patients with psoriasis, the clinical response to tapinarof is notable for durable remission or near remission, maintained for an average of 130 days beyond treatment discontinuation in patients with psoriasis in phase 3 studies. Tapinarof is usually well tolerated but can induce a follicular inflammatory reaction and dermatitis in some patients. This narrative review covers the historical development of this molecule, safety and efficacy data from clinical trials conducted with various topical formulations, and practical considerations derived from our 15 years of clinical trial experience with the drug.

引用

页码：1168 / 1174

页数：7

共 26 条

[1]

[Anonymous], 2022, MED LETT DRUGS THER, V64, pe128

[2] Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial [J].

Bissonnette, R. ;

Bolduc, C. ;

Maari, C. ;

Nigen, S. ;

Webster, J. M. ;

Tang, L. ;

Lyle, M. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (12) :1516-1521

[3] The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof [J].

Bissonnette, Robert ;

Gold, Linda Stein ;

Rubenstein, David S. ;

Tallman, Anna M. ;

Armstrong, April W. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (01) :E35-E36

[4] Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent [J].

Bissonnette, Robert ;

Gold, Linda Stein ;

Rubenstein, David S. ;

Tallman, Anna M. ;

Armstrong, April .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) :1059-1067

[5]

Bissonnette R, 2010, ARCH DERMATOL, V146, P446, DOI 10.1001/archdermatol.2010.34

[6] A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis [J].

Cai, Lin ;

Chen, Gen-Hui ;

Lu, Qian-Jin ;

Zheng, Min ;

Li, Yu-Zhen ;

Chen, Jin ;

Zheng, Jie ;

Zhang, Fu-Ren ;

Yu, Jian-Bin ;

Yang, Sen ;

Li, Fu-Qiu ;

Xiao, Sheng-Xiang ;

Sun, Qiu-Ning ;

Xu, Jin-Hua ;

Gao, Xing-Hua ;

Fang, Hong ;

Gao, Tian-Wen ;

Hao, Fei ;

Liu, Quan-Zhong ;

Tu, Ya-Ting ;

Li, Ruo-Yu ;

Wang, Bao-Xi ;

Deng, Dan-Qi ;

Zheng, Qing-Shan ;

Liu, Hong-Xia ;

Zhang, Jian-Zhong .

CHINESE MEDICAL JOURNAL, 2020, 133 (24) :2905-2909

[7] Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation [J].

Fernandez-Gallego, Nieves ;

Sanchez-Madrid, Francisco ;

Cibrian, Danay .

CELLS, 2021, 10 (11)

[8] Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis [J].

Furue, Masutaka .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) :1-25

[9] Antibiotic production in relation to bacterial growth and nematode development in Photorhabdus Heterorhabditis infected Galleria mellonella larvae [J].

Hu, K ;

Webster, JM .

FEMS MICROBIOLOGY LETTERS, 2000, 189 (02) :219-223

[10]

Jett J, 2022, J DRUGS DERMATOL, V21, P1084, DOI [10.36849/JDD.6627R1, 10.36849/JDD.6627]

← 1 2 3 →